These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18288746)

  • 1. PFO closure devices: The disconnect between technology, technique, and indications for use.
    Feldman T
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):403-4. PubMed ID: 18288746
    [No Abstract]   [Full Text] [Related]  

  • 2. PFO closure in 2008: See through a glass, darkly.
    Carroll JD
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):388-9. PubMed ID: 18288736
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
    Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing a door.
    Butman S
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):396-7. PubMed ID: 18288738
    [No Abstract]   [Full Text] [Related]  

  • 6. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebound increase in migraines following PFO closure.
    Bhindi R; Ormerod OJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):719; author reply 720. PubMed ID: 18360874
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
    Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fascination with PFO's.
    Tobis J
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):417. PubMed ID: 18288749
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent foramen ovale closure: past, present and future.
    Steinberg DH; Pichard AD; Satler LF; Slack MC; Wunderlich N; Majunke N; Sievert H
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):881-91. PubMed ID: 17867918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: A case report.
    Motreff P; Dauphin C; Souteyrand G
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):412-6. PubMed ID: 18288748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
    Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
    Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging closure of a patent foramen ovale via a superior approach.
    Bhindi R; Wilson N; Ormerod OJ
    J Invasive Cardiol; 2008 Jan; 20(1):E18. PubMed ID: 18174624
    [No Abstract]   [Full Text] [Related]  

  • 18. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale closure and subsequent atrial fibrillation.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.